Description
Manufacturer
GLAXOSMITHKLINE LLC(UNITED STATES)
Registraction Number
MAL14115017ARZ
Pre-Dispensed Content:
Each inhalation delivers 92 micrograms of fluticasone furoate and 22 micrograms of vilanterol (as trifenatate), corresponding to a pre-dispensed dose of 100 micrograms of fluticasone furoate and 25 micrograms of vilanterol (as trifenatate).
Indications:
Relvar Ellipta is indicated for:
- Asthma: Regular treatment in adults and adolescents aged 12 years and older who are not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short-acting beta2-agonists.
- Chronic Obstructive Pulmonary Disease (COPD): Symptomatic treatment in adults with a FEV1 <70% predicted normal (post-bronchodilator) and an exacerbation history despite regular bronchodilator therapy.
Instructions:
- Check the dose counter to ensure there are doses left.
- Slide the cover down until a click is heard.
- Breathe out gently away from the device and place the mouthpiece between your teeth without biting.
- Breathe in strongly and deeply and hold your breath for 5-10 seconds or as long as comfortable.
- Remove the inhaler from your mouth while holding your breath.
- Breathe out gently away from the inhaler.
- Slide the cover upwards to cover the mouthpiece.
More detail about Complete Wellness